BCBSM, Inc. v. Walgreen Co.

District Court, N.D. Illinois·Decided September 29, 2025·No. 1:20-cv-01853·Unknown

Opinion

THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION BCBSM, INC, (d/b/a BLUE CROSS and BLUE ) SHIELD of MINNESOTA), HEALTH NEW )

YORK, INC, HORIZON HEALTHCARE )

SERVICES, INC. (d/b/a HORIZON BLUE )

CROSS BLUE SHIELD OF NEW JERSEY), )

BLUE CROSS AND BLUE SHIELD OF )

ARIZONA, INC. (d/b/a BLUE CROSS BLUE )

SHIELD OF ARIZONA and d/b/a AZBLUE), ) No. 20 C 1853 ASURIS NORTHWEST HEALTH, et al., ) No. 20 C 1929 ) No. 20 C 3332 Plaintiffs, ) No. 20 C 4940 v. ) No. 20 C 4738 )

WALGREEN CO. and WALGREENS BOOTS )

ALLIANCE, INC., ) Chief Judge Virginia M. Kendall )

Defendants and Third-Party Plaintiffs, )

) v. ) ) PRIME THERAPEUTICS LLC, ) ) Third-Party Defendant. )

MEMORANDUM OPINION AND ORDER

This consolidated lawsuit stems from Initial Plaintiffs’ claims of common law fraud, consumer fraud, deceptive trade practices, and unjust enrichment against Defendants Walgreen Co. and Walgreens Boots Alliance, Inc. After seven Additional Plaintiffs1 filed a nearly identical complaint, see CareFirst of Md., Inc., et al. v. Walgreen Co., et al., No. 1:22-cv-12 01362 (N.D.

1 CareFirst of Maryland, Inc.; Group Hospitalization and Medical Services, Inc.; CareFirst BlueChoice, Inc.; Blue Cross and Blue Shield of South Carolina; BlueChoice HealthPlan of South Carolina, Inc.; Louisiana Health Service & Indemnity Company, d/b/a/ Blue Cross and Blue Shield of Louisiana, and HMO Louisiana, Inc. (Dkt. 568 at 1). Ill.), the cases were consolidated in this action and then superseded by their operative second amended complaint. (See Dkt. 145); (Dkt. 272).2 On May 2, 2023, this Court appointed Dr. Maura R. Grossman as Special Master to address and resolve the issues raised in Walgreens’ Motion to Compel Document Discovery and Related

Metrics. (Dkt. 450). Both parties now move for sanctions relating to the opposing party’s conduct during discovery under the Special Master’s guidance. (Dkt. 643); (Dkt. 649). Walgreens seeks to dismiss Initial Plaintiffs’ claims or alternatively (1) to preclude Initial Plaintiffs from pursuing damages, interest, or costs accrued after their substantial-completion declaration and (2) allow adverse inference jury instructions. (Dkt. 643 at 2); (Dkt. 647 at 3). Walgreens also requests costs and fees from Initial Plaintiffs associated with the remediation process in the amount of $4,100,747, or, in the alternative, for Initial Plaintiffs to pay Walgreens’ reasonable attorney’s fees and expenses incurred in connection with filing its Motion to Compel. (Dkt. 647 at 37-38). Initial Plaintiffs requests costs and fees from Walgreens associated with the remediation process in the amount of $3,010,271. (Dkt. 649 at 1); (Dkt. 658 at 3). For the reasons stated below, the Court

grants Walgreens’ Motion in part [643] and denies Initial Plaintiffs’ Motion [649]. BACKGROUND

I. Overview of the Dispute

“Walgreens” refers to Defendants Walgreen Co. and Walgreens Boots Alliance, Inc. “Initial Plaintiffs” refers to BCBSM, Inc. (d/b/a Blue Cross and Blue shield of Minnesota); HMO Minnesota (d/b/a Blue Plus); Health Options, Inc. (d/b/a Florida Blue HMO); Blue Cross and Blue Shield of North Carolina; Blue Cross Blue Shield of North Dakota; Blue Cross and Blue Shield of Florida, Inc. (d/b/a Florida Blue); Blue Cross and Blue Shield of Alabama; Blue Cross and Blue Shield of Kansas, Inc.; Blue Cross and Blue Shield of Massachusetts, Inc.; Blue Cross and Blue Shield of Massachusetts HMO Blue, Inc.; Wellmark, Inc. (d/b/a Wellmark Blue Cross and Blue Shield and d/b/a Wellmark Blue Cross and Blue Shield of Iowa); Wellmark of South Dakota, Inc. (d/b/a Wellmark Blue Cross and Blue Shield of South Dakota); Wellmark Health Plan of Iowa, Inc.; Wellmark Synergy Health, Inc.; Wellmark Value Health Plan, Inc.; Blue Cross and Blue Shield of Arizona, Inc. (d/b/a Blue Cross Blue Shield of Arizona and d/b/a AZBLUE); Blue Cross and Blue Shield of Kansas City, Inc.; HealthNow New York, Inc.; Highmark Western New York, Inc. (f/k/a Blue Cross of Western New York); Northeastern New York (f/k/a BlueShield of Northeastern New York); Horizon Healthcare Services, Inc. (d/b/a Horizon Blue Cross Blue Shield of New Jersey); and Horizon Healthcare of New Jersey, Inc. (d/b/a Horizon NJ Health). (Dkt. 636 at 1). The parties’ Motions stem from a discovery dispute, which culminated in a two-year remediation process. Walgreens claims that Initial Plaintiffs withheld responsive, case-critical materials, while knowing that they had produced these materials to CVS in a very similar, previous matter. (Dkt. 647 at 1). According to Walgreens, Initial Plaintiffs declared that they had

substantially completed document production yet had provided less than 18,000 of the 470,000 documents that they eventually produced and that Walgreens was entitled to receive. (Dkt. 647 at 10). In their Motion, Initial Plaintiffs allege that Walgreens manipulated the Special Master process in bad faith to inflate the number of responsive documents, which Initial Plaintiffs had failed to identify, to strengthen Walgreens’ collateral relief Motion. (Dkt. 658 at 13–14). A. Problems Before the Special Master The details of the discovery issues which led to the pending Motions are as follows: In May 2021, Walgreens served its first Requests for Production (RFPs) on Initial Plaintiffs. (Dkt. 642 at 4). Initial Plaintiffs responded to Walgreens’ RFPs in July 2021. (Dkt. 662, Exhibit 4). On June 15, 2021, Court entered the parties’ Stipulated Order regarding Electronically Stored Information

(“ESI”) Case Management Protocol on June 15, 2021. (Dkt. 140, Stipulated Order). The parties agreed that each Party will use one or more search methodologies to collect, review, and produce responsive, non-privileged ESI and other documents in response to discovery requests. Such methodologies include the use of search terms, filters, and technology-assisted review.

(Id. at 2). Because of the large number of documents that hit on the agreed search terms, Initial Plaintiffs engaged a third-party litigation support vendor, Consilio, to provide, maintain, and support Initial Plaintiffs in their document review and productions, including the use of a technology-assisted review (“TAR”) search method. (Dkt. 681 at 5; Dkt. 658 at 4). Specifically, they relied on a program commonly referred to as a “Continuous Active Learning,” (“CAL”). (Dkt. 681 at 5). This technology involves the creation of a computer model/algorithm that is updated during the review for the purpose of identifying potentially responsive documents as documents are reviewed and coded for training purposes. (Id.) On December 24, 2021, Initial Plaintiffs sent a

letter to clarify and confirm the scope of their agreed upon responsive documents to Walgreens’ RFPs. (Dkt. 655-18 at 257, Exhibit 18 – Letter from Monica R. Sterling). To utilize the program, Initial Plaintiffs had to train the computer model by having attorneys review and code documents for responsiveness. (Id.) This process began in October 2021. (Id.) Initial Plaintiffs created an algorithm in their TAR model, which the program continually updated, to identify responsive documents, while attorney reviewers coded documents as either responsive or non-responsive. (Dkt. 658 at 4). Initial Plaintiffs claim this human review was “intentionally overbroad” because the scope of responsiveness was still being negotiated, the sample data set was incomplete, and contract attorneys had to conduct additional review. (Id.) During this process, Initial Plaintiffs calculated a “cut-off” score of 64. (Id. at 6). This meant that

the program learned to identify any document, which received a responsiveness score of 64 or above. (Id.) Through July 2022, Walgreens challenged the slow pace of document production. (Dkt.

Free access — add to your briefcase to read the full text and ask questions with AI

BCBSM, Inc. v. Walgreen Co., (N.D. Ill. 2025).

BCBSM, Inc. v. Walgreen Co. (BCBSM, Inc. v. Walgreen Co.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Pierce v. Underwood
487 U.S. 552 (Supreme Court, 1988)
Chambers v. Nasco, Inc.
501 U.S. 32 (Supreme Court, 1991)
Carmelo Melendez v. Illinois Bell Telephone Company
79 F.3d 661 (Seventh Circuit, 1996)
Collins v. Illinois
554 F.3d 693 (Seventh Circuit, 2009)
Illinois Tool Works, Inc. v. Metro Mark Products, Ltd.
43 F. Supp. 2d 951 (N.D. Illinois, 1999)
MacNeil Automotive Products, Ltd. v. Cannon Automotive Ltd.
715 F. Supp. 2d 786 (N.D. Illinois, 2010)
Delores Henry v. Melody Hulett
969 F.3d 769 (Seventh Circuit, 2020)
Kenall Mfg. Co. v. Cooper Lighting, LLC
354 F. Supp. 3d 877 (E.D. Illinois, 2018)
Ramirez v. T&H Lemont, Inc.
845 F.3d 772 (Seventh Circuit, 2016)
In re Sulfuric Acid Antitrust Litigation
231 F.R.D. 320 (N.D. Illinois, 2005)